维普中文期刊产品整合服务
121篇 您的检索式:作者名="Habermann TM"
    题名 作者 年代 出处 被引量
1Bowe perforation in intestinal lymphoma:incidence and clinica features显示文摘Vaidya R Habermann TM Donohue JH 2013Ann Oncol2013,24,9:1
2Risk of lymphoma in inflammatory bowel disease 显示文摘 Tremaine WJ Habermann TM 2000Am J Gastroenterot2000,95,9:1
3RituximabCHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma显示文摘Habermann TM Weller EA Morrison VA 2006J Clin Oncol2006,24,19:1
4Testicular lymphoma is associated with a high incidence of extranodal recurrence显示文摘Fonseca R Habermann TM Colgan JP 2000Cancer2000,88,1:1
5Primary thyroid lymphoma显示文摘Ansell SM Grant CS Habermann TM 1999Semin Oncol1999,26,3:1
6Increasing use of contralateral prophylactic mastectomy for breast cancer patients : a trend toward more aggressive surgical treatment显示文摘Tuttle TM Habermann EB Grund EH 2007J Clin Oncol2007,25,2:1
7Rituximab- CHOP versus CHOP alone or with maintenancerituximab in older patients with diffuse large B-cell lymphoma 显示文摘Habermann TM Weller EA Morrison VA 2006J Clin Oncol2006,24,19:1
8Periph- eral blood lymphocyte/monocyte ratio at diagnosis and survival in nodular lymphocyte-predominant Hodgkin lymphoma显示文摘Porrata LF Ristow K Habermann TM 2012Br J Haematol2012,157,3:1
9The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphoma显示文摘Wilcox RA Ristow K Habermann TM 2011Leukemia2011,25,9:1
10Rituximab - CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B - cell lymphoma显示文摘Habermann TM Weller EA Morrison VA 2006J Clin Oncol2006,24,19:1
11Rituximab CHOP velsus CHOP alone or with maintenance rituximab in B - cell lympho- ma显示文摘Habermann TM Weller EA Morrisen VA 2006J Clin Oncol2006,24,19:1
12Peripheral blood lym- phoeyte/monoeyte ratio at diagnosis and survival in nodular lym- phocytepredominant Hodgkin lymphoma显示文摘Porrata LF Ristow K Habermann TM 2012Br J Haematol2012,157,3:1
13Comparison of con- ventional prognostic indices in patients older than 60 years with diffuse large B-cell lymphoma treated with R-CHOP in the US Intergroup Study (ECOG 4494, CALGB 9793): consideration of age greater than 70 years in an elderly prognostic index (E- IPI) 显示文摘Advani RH Chen H Habermann TM 2010BrJ Haematol2010,151,2:1
14Primary thyroidlymphoma显示文摘Ansell SM Grant CS Habermann TM 1999Semin Oncol1999,26,3:1
15Ritux-imab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma显示文摘Habermann TM Weller EA Morrison VA 2006J Clin Oncol2006,24,19:1
16Rituximab- CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma 显示文摘Habermann TM Weller EA Morrison VA 2006J Clin Oncol2006,24,19:1
17Absolute lymphocyte count at the time of first relapse predicts survival in patients with diffuse large B-cell lymphoma显示文摘Porrata LF Ristow K Habermann TM 2009Am J Hematol2009,84,2:1
18The absolutemono- cyte and lymphocyte prognostic score predictssurvival and identi- fies high-risk patientsin diffuse large-B-cell lymphoma显示文摘Wilcox RA Ristow K Habermann TM 2011Leuke-mia2011,25,9:1
19Primary thyroid lymphoma显示文摘Ansell SM Grant CS Habermann TM 2000Semin Oncol2000,26,3:1
20CD4^+ T-cell immune response to large B-cell non-Hodgkin's lymphoma predicts patient outcome显示文摘Ansell SM Stenson M Habermann TM 2001J Clin Oncol2001,19,3:1
返回顶部 每页显示:
共7页 首页 上一页 第1页 下一页 末页 /7 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费